AMGN analyst estimates
Amgen (AMGN) analyst ratings, the average price target and its range, and every firm's latest call.
AMGN analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 23, 2026 | Oppenheimer | Amgen (AMGN) PT Raised to $480 at OppenheimerMember Login | $480.00 |
| Oct 21, 2026 | Barclays | Amgen price target raised to $400 from $380 at Barclays | $400.00 |
| Oct 13, 2026 | Guggenheim | Amgen price target lowered to $378 from $388 at Guggenheim | $378.00 |
| Oct 12, 2026 | Wells Fargo | Amgen price target lowered to $430 from $435 at Wells Fargo | $430.00 |
| Oct 12, 2026 | BMO Capital | Amgen price target lowered to $415 from $450 at BMO Capital | $415.00 |
| Oct 8, 2026 | Cantor Fitzgerald | Amgen (AMGN) PT Raised to $440 at Cantor Fitzgerald - 'Now a Clear Consensus Long' | $440.00 |
| Oct 8, 2026 | RBC Capital | Amgen price target raised to $430 from $400 at RBC Capital | $430.00 |
| Oct 7, 2026 | Truist Financial | Amgen price target raised to $380 from $362 at Truist | $380.00 |
| Sep 28, 2026 | Scotiabank | Amgen price target raised to $500 from $450 at Scotiabank | $500.00 |
| Sep 23, 2026 | Jefferies | Amgen (AMGN) PT Raised to $410 at Jefferies | $410.00 |
| Sep 17, 2026 | UBS | Amgen (AMGN) PT Lowered to $430 at UBS | $430.00 |
| Sep 4, 2026 | Wells Fargo | Amgen (AMGN) PT Raised to $435 at Wells Fargo | $435.00 |
| Aug 20, 2026 | Piper Sandler | Amgen price target raised to $457 from $427 at Piper Sandler | $457.00 |
| Aug 19, 2026 | Argus Research | Amgen price target raised to $460 from $375 at Argus | $460.00 |
| Aug 19, 2026 | Morgan Stanley | Amgen price target raised to $362 from $351 at Morgan Stanley | $362.00 |
- 21 firms rate AMGN: 8 buy, 13 hold, 0 sell.
- The average price target is $426.57 from 14 analysts, from $362.00 to $500.00.
Updated 2026-11-02 17:52 UTC